REGENERON PHARMACEUTICALS, INC v KYMAB LTD (No. 2). Issue 8 (6th December 2018)

• Record Type: Journal Article
• Is Part Of: Reports of patent, design and trade mark cases. Volume 135:Issue 8(2018)
• Page Start: 605
• Page End: 624
• Publication Date: 2018-12-06
• Subjects: Patent laws and legislation -- Great Britain -- Cases; Patent infringement -- Great Britain -- Cases; Industrial property -- Law and legislation -- Great Britain -- Cases; Patents -- Great Britain -- Periodicals; 346.41048
• DOI: 10.1093/rpc/rcy044
• Languages: English
• ISSNs: 0080-1364

Abstract

Abstract: Patents – European patents – Pharmaceuticals – Antibody production – Genetic engineering – Transgenic mice – Infringement – Validity – Appeal to Court of Appeal – Decision below overturned – Terms of injunctive relief – Whether to extend to non-infringing eukaryotic cells – Scope of disclosure to be ordered – Costs on appeal and below – Successful argument not advanced below – Apportionment as between co-defendants – Interim costs order – Stay pending further appeal – Whether to impose conditions